Jacobs Solutions Inc. : Doji in weekly data
Entry price | Target | Stop-loss | Potential |
---|
$42.9 |
$0 |
$40.4 |
-100% |
---|
Jacobs Engineering is one of the world’s largest and most diverse providers of professional technical services. The company offers support to industrial, commercial and government clients across different markets as aerospace and defense, automotive, buildings, oil and gas, chemicals, energy and others.
The company recorded a full year 2011 revenues above $10 380 million, up 4.5% and diluted earnings per share of $2.60 up 32%. More then 75% of its turnover is registered in North America, with 60% only in the United States. The 2012 turnover is estimated above $11.250 million according to Thomson Reuters’ data. The company currently trades at 14x Thomson Reuters’ 2012 earnings per share estimate.
Jacobs Engineering stock during last year underperformed the S&P 500. Since early of the year the share gained nearly 6.5% ; the bullish movement was cut after a correction set up during the past weeks. This correction led the stock close to long-term support of USD 41.5 and in weekly data on the 100 periods moving average. This level could lead a rebound and might push the stock towards a long-term resistance of USD 47.6. We suggest a stop loss below USD 41.5
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.